Medulloblastoma: Progress over time

Journal of Medical Imaging and Radiation Oncology

Volumn 56, Issue 2, 2012, Pages 227-234

  Smee, Robert I ^a   Williams, Janet R ^a   De loyde, Katie J ^a   Meagher, Nicola S ^b   Cohn, Richard ^c  

^a The Prince of Wales Cancer Centre   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c SYDNEY CHILDREN'S HOSPITAL   (Australia)

Author keywords

Chemotherapy; Craniospinal; High risk versus low risk; Medulloblastoma; Radiotherapy

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; CYCLOPHOSPHAMIDE; PLATINUM; VINCRISTINE;

ADOLESCENT; ARTICLE; BRAIN HEMANGIOMA; BRAIN SURGERY; CANCER CHEMOTHERAPY; CANCER LOCALIZATION; CANCER MORTALITY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CHILD; DRUG MEGADOSE; FEMALE; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDULLOBLASTOMA; MENINGIOMA; OUTCOME ASSESSMENT; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RADIATION DOSE; RECURRENT DISEASE; RETROSPECTIVE STUDY; SCHOOL CHILD; STEM CELL TRANSPLANTATION; SURVIVAL TIME;

CENTRAL NERVOUS SYSTEM NEOPLASMS; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MEDULLOBLASTOMA; NEOPLASM RECURRENCE, LOCAL; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES; SURVIVAL RATE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84859800762     PISSN: 17549477     EISSN: 17549485     Source Type: Journal    
DOI: 10.1111/j.1754-9485.2012.02349.x     Document Type: Article

References (30)

1. Kun LE, MacDonald S, Tarbell NJ. Tumours of the posterior fossa and the spinal canal. In: Pine JW (ed.). Pediatric Radiation Oncology, 5th edn. Williams and Wilkins, Philadelphia, 2011; 53-84.
2. Garrè ML, Cama A, Bagnasco F et al. Medulloblastoma variants: age-dependent occurrence and relation to Gorlin syndrome. A new clinical perspective. Clin Cancer Res 2009; 15 (7): 2463-71.
3. Feltbower RG, Picton S, Bridges LR, Crooks DA, Glaser AW, McKinney PA. Epidemiology of central nervous system tumors in children and young adults (0-29 years), Yorkshire, United Kingdom. Pediatr Hematol Oncol 2004; 21 (7): 647-60. (Pubitemid 39336822)
4. De Bont JM, Packer RJ, Michiels EM, Den Boer ML, Pieters R. Biological background of pediatric medulloblastoma and ependymoma: a review from a translational research perspective. Neuro Oncol 2008; 10 (6): 1040-60.
5. Gaspar LE, Dawson DJ, Tilley-Gulliford SA, Banerjee P. Medulloblastoma: long-term follow-up of patients treated with electron irradiation of the spinal field. Radiology 1991; 180 (3): 867-70.
6. Merchant TE, Kun LE, Krasin MJ et al. Multi-institution prospective trial of reduced-dose craniospinal irradiation (23.4 Gy) followed by conformal posterior fossa (36 Gy) and primary site irradiation (55.8 Gy) and dose-intensive chemotherapy for average-risk medulloblastoma. Int J Radiat Oncol Biol Phys 2008; 70 (3): 782-7. (Pubitemid 351199711)
7. Carrie C, Muracciole X, Gomez F et al. Conformal radiotherapy, reduced boost volume, hyperfractionated radiotherapy, and online quality control in standard-risk medulloblastoma without chemotherapy: results of the French M-SFOP 98 protocol. Int J Radiat Oncol Biol Phys 2005; 63 (3): 711-16. (Pubitemid 41400056)
8. Gajjar A, Hernan R, Kocak M et al. Clinical, histopathologic, and molecular markers of prognosis: toward a new disease risk stratification system for medulloblastoma. [see comment]. J Clin Oncol 2004; 22 (6): 984-93. (Pubitemid 41095029)
9. Lamont JM, McManamy CS, Pearson AD, Clifford SC, Ellison DW. Combined histopathological and molecular cytogenetic stratification of medulloblastoma patients. Clin Cancer Res 2004; 10 (16): 5482-93. (Pubitemid 39100486)
10. Albright AL, Wilsoff JH, Zeltzer PM, Boyett JM, Rorke LB, Stanley P. Effects of medulloblastoma resections on outcome in children: a report from the children's cancer group. Neurosurgery 1996; 38 (2): 265-71. (Pubitemid 26030705)
11. Fukunaga-Johnson N, Lee JH, Sandler HM, Robertson P, McNeil E, Goldwein JW. Patterns of failure following treatment for medulloblastoma: is it necessary to treat the entire posterior fossa? Int J Radiat Oncol Biol Phys 1998; 42 (1): 143-6. (Pubitemid 28445521)
12. Gajjar A, Chintagumpala M, Ashley D et al. Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial. Lancet Oncol 2006; 7 (10): 813-20. (Pubitemid 44464063)
13. Gilbertson RJ, Langdon JA, Hollander A et al. Mutational analysis of PDGFR-RAS/MAPK pathway activation in childhood medulloblastoma. Eur J Cancer 2006; 42 (5): 646-9. (Pubitemid 43343687)
14. Robertson PL, Muraszko KM, Holmes EJ et al. Incidence and severity of postoperative cerebellar mutism syndrome in children with medulloblastoma: a prospective study by the Children's Oncology Group. J Neurosurg 2006; 105 (6): 444-51. (Pubitemid 44968374)
15. Gudrunardottir T, Sehested A, Juhler M, Schmiegelow K. Cerebellar mutism. Childs Nerv Syst 2010; 27 (3): 355-63.
16. Parker W, Filion E, Roberge D et al. Intensity-modulated radiotherapy for craniospinal irradiation: target volume considerations, dose constraints, and competing risks. [see comment]. Int J Radiat Oncol Biol Phys 2007; 69 (1): 251-7. (Pubitemid 47247522)
17. St Clair WH, Adams JA, Bues M et al. Advantage of protons compared to conventional X-ray or IMRT in the treatment of a pediatric patient with medulloblastoma. Int J Radiat Oncol Biol Phys 2004; 58 (3): 727-34. (Pubitemid 38221128)
18. Baker KC, Isert PR. Anaesthetic considerations for children undergoing stereotactic radiotherapy. Anaesth Intensive Care 1997; 25: 691-5. (Pubitemid 28021466)
19. Mu X, Bjork-Eriksson T, Nill S et al. Does electron and proton therapy reduce the risk of radiation induced cancer after spinal irradiation for childhood medulloblastoma? A comparative treatment planning study. Acta Oncol 2005; 44 (6): 554-62. (Pubitemid 41503601)
20. Verlooy J, Mosseri V, Bracard S et al. Treatment of high risk medulloblastomas in children above the age of 3 years: a SFOP study. Eur J Cancer 2006; 42 (17): 3004-14. (Pubitemid 44667471)
21. Taylor RE, Bailey CC, Robinson KJ et al. Outcome for patients with metastatic (M2-3) medulloblastoma treated with SIOP/UKCCSG PNET-3 chemotherapy. Eur J Cancer 2005; 41 (5): 727-34. (Pubitemid 40342556)
22. Huber JF, Bradley K, Spiegler B, Dennis M. Long-term neuromotor speech deficits in survivors of childhood posterior fossa tumors: effects of tumor type, radiation, age at diagnosis, and survival years. J Child Neurol 2007; 22 (7): 848-54. (Pubitemid 47261237)
23. Mulhern RK, Palmer SL, Merchant TE et al. Neurocognitive consequences of risk-adapted therapy for childhood medulloblastoma. J Clin Oncol 2005; 23 (24): 5511-19.
24. Xu W, Janss A, Packer RJ, Phillips P, Goldwein J, Moshang T Jr. Endocrine outcome in children with medulloblastoma treated with 18 Gy of craniospinal radiation therapy. Neuro Oncol 2004; 6 (2): 113-18. (Pubitemid 38455757)
25. Merchant TE, Kiehna EN, Li C et al. Modeling radiation dosimetry to predict cognitive outcomes in pediatric patients with CNS embryonal tumors including medulloblastoma. Int J Radiat Oncol Biol Phys 2006; 65 (1): 210-21.
26. Stavrou T, Bromley CM, Nicholson HS et al. Prognostic factors and secondary malignancies in childhood medulloblastoma. J Pediatr Hematol Oncol 2001; 23 (7): 431-6. (Pubitemid 33031771)
27. Ahern V, Koh ES, Gebski V, Sathiyaseelan Y. Paediatric medulloblastoma: patterns of care and radiotherapy quality assurance in Australia. Australas Radiol 2007; 51 (5): 458-64. (Pubitemid 47366554)
28. Packer RJ, Rood BR, MacDonald TJ. Medulloblastoma: present concepts of stratification into risk groups. Pediatr Neurosurg 2003; 39 (2): 60-7. (Pubitemid 36829097)
29. Zeltzer PM, Boyett JM, Finlay JL et al. Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children: conclusions from the children's cancer group 921 randomized phase III study. J Clin Oncol 1999; 17 (3): 832-45. (Pubitemid 29109313)
30. Akyuz C, Varan A, Kupeli S et al. Medulloblastoma in children: a 32-year experience from a single institution. J Neurooncol 2008; 90 (1): 99-103.